# Gary H. Lyman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gary-h-lyman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 78,631 |
| Field | Neutropenia and Cancer Infections |
| h-index | 129 |
| i10-index | 462 |
| OpenAlex ID | https://openalex.org/A5073060840 |
| ORCID iD | https://orcid.org/0000-0002-0823-8086 |
| Works | 951 |

## Researcher papers

Showing 12 of 17.

- [Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System](https://scholariq.org/papers/prognostic-factors-analysis-of-17-600-melanoma-patients-validation-of-the/)
- [American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer](https://scholariq.org/papers/american-society-of-clinical-oncology-guideline-recommendations-for-sentinel/)
- [Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study](https://scholariq.org/papers/clinical-impact-of-covid-19-on-patients-with-cancer-ccc19-a-cohort-study/)
- [2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline](https://scholariq.org/papers/2006-update-of-recommendations-for-the-use-of-white-blood-cell-growth-factors-an/)
- [American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline](https://scholariq.org/papers/american-cancer-society-american-society-of-clinical-oncology-breast-cancer/)
- [Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update](https://scholariq.org/papers/sentinel-lymph-node-biopsy-for-patients-with-early-stage-breast-cancer-american/)
- [Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update](https://scholariq.org/papers/recommendations-for-the-use-of-wbc-growth-factors-american-society-of-clinical/)
- [American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options](https://scholariq.org/papers/american-society-of-clinical-oncology-statement-a-conceptual-framework-to-assess/)
- [American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer](https://scholariq.org/papers/american-society-of-hematology-2021-guidelines-for-management-of-venous/)
- [American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline](https://scholariq.org/papers/american-cancer-society-american-society-of-clinical-oncology-breast-cancer-2/)
- [Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer](https://scholariq.org/papers/rivaroxaban-for-thromboprophylaxis-in-high-risk-ambulatory-patients-with-cancer/)
- [A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.](https://scholariq.org/papers/a-phase-iii-randomized-study-comparing-cisplatin-and-fluorouracil-as-single/)

## Researcher topics

- [Neutropenia and Cancer Infections](https://scholariq.org/topics/neutropenia-and-cancer-infections/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)
- [Blood disorders and treatments](https://scholariq.org/topics/blood-disorders-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.